Total Payments
$374,525
2024 Payments
$85,890
Companies
14
Transactions
514
Medicare Patients
5,338
Medicare Billing
$370,284
Payment Breakdown by Category
Other$260,818 (69.6%)
Travel$49,145 (13.1%)
Consulting$48,639 (13.0%)
Food & Beverage$9,575 (2.6%)
Research$6,348 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $260,818 | 84 | 69.6% |
| Travel and Lodging | $49,145 | 193 | 13.1% |
| Consulting Fee | $48,639 | 20 | 13.0% |
| Food and Beverage | $9,575 | 175 | 2.6% |
| Unspecified | $6,348 | 42 | 1.7% |
Payments by Type
General
$368,177
472 transactions
Research
$6,348
42 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $225,017 | 309 | $0 (2024) |
| GENZYME CORPORATION | $112,970 | 121 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $21,160 | 59 | $0 (2024) |
| Stemline Therapeutics Inc. | $4,800 | 3 | $0 (2022) |
| Merck Sharp & Dohme LLC | $4,656 | 3 | $0 (2023) |
| ADC Therapeutics America, Inc. | $3,000 | 1 | $0 (2022) |
| KADMON PHARMACEUTICALS LLC | $2,238 | 4 | $0 (2020) |
| Deciphera Pharmaceuticals Inc. | $205.17 | 4 | $0 (2024) |
| Incyte Corporation | $144.45 | 2 | $0 (2023) |
| Novocure Inc. | $91.29 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,890 | 113 | Regeneron Healthcare Solutions, Inc. ($75,637) |
| 2023 | $51,102 | 85 | Regeneron Healthcare Solutions, Inc. ($47,974) |
| 2022 | $88,121 | 117 | Regeneron Healthcare Solutions, Inc. ($45,334) |
| 2021 | $81,416 | 77 | GENZYME CORPORATION ($60,073) |
| 2020 | $8,317 | 11 | GENZYME CORPORATION ($4,519) |
| 2019 | $56,022 | 81 | Regeneron Healthcare Solutions, Inc. ($41,547) |
| 2018 | $3,597 | 29 | Regeneron Pharmaceuticals, Inc. ($2,316) |
| 2017 | $60.81 | 1 | MERZ NORTH AMERICA, INC. ($60.81) |
All Payment Transactions
514 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $1,336.00 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,804.00 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,804.00 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $120.72 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,340.00 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $735.23 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $214.60 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $83.90 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,804.00 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $121.50 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,804.00 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $91.29 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $455.48 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $120.00 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $63.31 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $5.00 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Libtayo Clinical Publication Program | Regeneron Pharmaceuticals, Inc. | $3,309 | 22 |
| LIBTAYO CLINICAL PUBLICATION PROGRAM | Regeneron Pharmaceuticals, Inc. | $3,039 | 20 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,407 | 2,142 | $443,625 | $107,853 |
| 2022 | 20 | 1,566 | 2,275 | $441,952 | $112,769 |
| 2021 | 19 | 1,442 | 2,089 | $394,449 | $104,917 |
| 2020 | 17 | 923 | 1,390 | $210,133 | $44,746 |
Total Patients
5,338
Total Services
7,896
Medicare Billing
$370,284
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 223 | 303 | $77,568 | $23,335 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 209 | 269 | $44,923 | $14,545 | 32.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 123 | 123 | $55,473 | $13,085 | 23.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 172 | 219 | $38,544 | $10,148 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 130 | 130 | $40,560 | $8,467 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 83 | $21,248 | $6,651 | 31.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Facility | 2023 | 30 | 31 | $22,785 | $6,609 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 31 | 34 | $12,920 | $4,093 | 31.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 19 | 19 | $22,990 | $4,057 | 17.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Facility | 2023 | 30 | 35 | $20,423 | $3,404 | 16.7% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 118 | 126 | $15,682 | $3,181 | 20.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 41 | 50 | $8,950 | $2,977 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $6,684 | $1,708 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $6,637 | $1,525 | 23.0% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 35 | 37 | $5,781 | $1,421 | 24.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 131 | 617 | $30,233 | $1,074 | 3.6% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Facility | 2023 | 11 | 11 | $10,131 | $1,043 | 10.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Facility | 2023 | 20 | 29 | $2,094 | $529.49 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 249 | 364 | $93,184 | $29,680 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 152 | 152 | $68,552 | $17,132 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 261 | 297 | $49,599 | $16,712 | 33.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 170 | 170 | $53,040 | $11,570 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 193 | 231 | $40,656 | $10,921 | 26.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Facility | 2022 | 22 | 22 | $12,837 | $3,263 | 25.4% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2022 | 112 | 123 | $15,309 | $3,057 | 20.0% |
About Dr. Badri Modi, MD
Dr. Badri Modi, MD is a Dermatology healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1457613986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Badri Modi, MD has received a total of $374,525 in payments from pharmaceutical and medical device companies, with $85,890 received in 2024. These payments were reported across 514 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($260,818).
As a Medicare-enrolled provider, Modi has provided services to 5,338 Medicare beneficiaries, totaling 7,896 services with total Medicare billing of $370,284. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Duarte, CA
- Active Since 06/11/2012
- Last Updated 11/07/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1457613986
Products in Payments
- LIBTAYO (Biological) $340,319
- LIBTAYO (Drug) $13,483
- LIBTAYO CEMIPLIMAB-RWLC INJECTION (Biological) $3,584
- ELZONRIS (Drug) $2,700
- DUPIXENT (Biological) $221.46
- QINLOCK (Drug) $205.17
- JAKAFI (Drug) $125.00
- Optune (Device) $91.29
- Poteligeo (Drug) $72.14
- VOQUEZNA (Drug) $51.96
- Otezla (Drug) $44.42
- KEYTRUDA (Biological) $20.94
- OPZELURA (Drug) $19.45
- POTELIGEO (Drug) $13.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Duarte
Dr. Christiane Querfeld, Md, Phd, MD, PHD
Dermatology — Payments: $109,293
Dermatology $109,293
Dr. Farah Abdulla, Md, MD
Dermatology — Payments: $19,096
Dermatology $19,096
Dr. Courtney Johnson, Md, Phd, MD, PHD
Dermatology — Payments: $100.88
Dermatology $100.88
Irene Lao, M.d, M.D
Dermatology
Dermatology